CAS 334994-34-2

Formel: C41H58N8O7

InChl: InChI=1S/C41H58N8O7/c1-4-5-12-32(42)37(51)47-33(20-28-14-16-31(50)17-15-28)38(52)46-30(19-26(2)3)24-44-34(22-29-23-43-25-45-29)40(54)49-18-9-13-36(49)39(53)48-35(41(55)56)21-27-10-7-6-8-11-27/h6-8,10-11,14-17,23,25-26,30,32-36,44,50H,4-5,9,12-13,18-22,24,42H2,1-3H3,(H,43,45)(H,46,52)(H,47,51)(H,48,53)(H,55,56)/t30-,32-,33?,34-,35-,36-/m0/s1

InChI Key: LOHDEFSMLITXTG-RZAPKHMUSA-N

SMILES: CCCC[C@@H](C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)CN[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)N

Norleual

CAS: 334994-34-2

Norleual

Formel: C₄₁H₅₈N₈O₇

Reinheit: ≥97%

Molekulargewicht: 774.95

Ref: 54-OR1137827

Norleual

CAS: 334994-34-2

Angiotensin IV analog, potent HGF/c-MET inhibitor (IC50=3 pM), halts MDCK cell growth and invasion, AT4 antagonist, impairs LTP, antiangiogenic.

Formel: C₄₁H₅₈N₈O₇

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 774.95

Ref: TM-TP1990

Norleual

CAS: 334994-34-2

Formel: C₄₁H₅₈N₈O₇

Reinheit: 97%

Molekulargewicht: 774.9486

Ref: IN-DA01ENM3

Norleual

CAS: 334994-34-2

Norleual is a molecule that has been found to have anticancer activity. It inhibits the c-jun-n-terminal kinase (JNK) pathway in cancer cells, which activates the cell's growth factor receptors. Norleual also inhibits insulin resistance and has an inhibitory effect on receptor activity. This drug may be useful for the treatment of cancer and other diseases with receptor-related signaling pathways.

Formel: C₄₁H₅₈N₈O₇

Reinheit: Min. 95%

Molekulargewicht: 774.9 g/mol

Ref: 3D-JNA99434